Source: PharmAust
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • PharmAust (PAA) receives a $708,000 research and development tax incentive refund
  • The company says the Australian Taxation Office (ATO) has recognised the research and development innovation of the clinical-stage biotechnology company’s wholly-owned subsidiaries, Epichem and Pitney Pharmaceuticals
  • The R&D incentive scheme is a program jointly administered by the ATO and AusIndustry, under which companies can receive up to a 43.5 per cent refundable tax offset of eligible expenses on research activities
  • PAA shares up 1.1 per cent to 9.2 cents

PharmAust (PAA) has received a $708,000 research and development tax incentive refund.

The company said the Australian Taxation Office (ATO) recognised the research and development innovation of the clinical-stage biotechnology company’s wholly owned subsidiaries, Epichem and Pitney Pharmaceuticals.

Following approval from the ATO, just over $708,000 was deemed refundable on PharmAust’s 2021 tax return and paid to the company.

The research and development incentive scheme is a program jointly administered by the ATO and AusIndustry, under which companies can receive up to a 43.5 per cent refundable tax offset on eligible expenses on research and development activities.

“We appreciate the continued support and acknowledgement by the Australian Government for the critical work undertaken in our R&D programs,” PharmAust Finance Director Sam Wright said.

“The receipt of the R&D refund strengthens PharmAust’s financial position to execute on our upcoming clinical trials.”

PAA shares were up 1.1 per cent to 9.2 cents at 10:33 am AEST.

PAA by the numbers
More From The Market Herald
Countplus (ASX:CUP) - Incoming CEO, Hugh Humphrey

" Hugh Humphrey appointed CEO of Countplus (ASX:CUP)

Investment services company CountPlus (ASX:CUP) has appointed Hugh Humphrey as the company's CEO, effective July 1.

" ASX employee tests positive for Covid-19

The ASX says an employee has contracted Covid-19.

" ASIC launches official investigation into ASX market outage

The ASX has confirmed today it is officially under investigation from the Australian Securities and Investments…

" ASX sheds more light on last week’s market tech failure

The Australian Securities Exchange has shed some more light on the nature of last week's market…